Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Obamacare Repeal May Be Delaying User Fee Bill, Rep. DeGette Says

Executive Summary

House Energy and Commerce Committee Democrat says few in-depth member talks about the user fee bill have taken place because of focus on ACA repeal and replacement.


Related Content

User Fee Bill Could Become Ensnared In US Abortion Politics
Drug Pricing Bill May Make Six-Month ANDA Review Slower Than Eight-Month Review
CDER’s 50 Open Leadership Posts Could Be Bigger Hiring Challenges After Trump Freeze
FDA's Next Commissioner: Will Trump Follow Hamburg Or McClellan 'Schedule'?
FDA Commissioner Candidate Gulfo Hates Breakthrough, Wants To Reevaluate User Fees
Next Steps On US FDA Hiring: Lobby For Strong Long-Term Plan After Freeze Is Lifted
HHS Nominee Price Sidesteps Medicare Drug Pricing Negotiation Questions
PDUFA VI: Industry Ready For 'Hard Sell' To Keep Agreement Intact
Sen. Burr Tries To Pull FDASIA Over For Speeding As Senate Sends Bill To White House
Congress Approves FDA Reform/User Fee Bill In The Nick Of Time





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts